THE SILVER DRESSINGWITH MORE POSITIVES

THE SILVER DRESSINGWITH MORE POSITIVES

Quickly Kills 99.999% of a broad spectrum of bacteria1

Disrupts and breaks down biofi lm to expose bacteria2

Kills bacteria for up to seven days1

Minimal stinging or pain3

Cost E� ective

THE POWER OF Ag OXYSALTS™ TECHNOLOGYSilver is only e� ective at killing bacteria when it loses electrons in exudate. The more electrons that are lost, the more positively charged the silver becomes. This leads to a greater ability of silver to disrupt the normal function of the bacteria4.

Exsalt® dressings with Ag Oxysalts™ Technology are designed to lose 3 electrons in exudate (Ag3+) to make it more e� ective at killing bacteria. Other silver dressings only lose one electron (Ag1+) making their silver less e� ective4.

Exsalt® is a silver dressing for chronic and acute wounds that utilizes Ag Oxysalts™ Technology. Ag Oxysalts™ is a unique type of silver that delivers a quick and strong bacteria kill rate while at the same time being gentle on patients and your budget.1-4 The result is a silver dressing with more positives.

Two outer layers of non-adherent high-density polyethylene (HDPE)

Can be applied wet or dry, cut to shape to fi t wound area, and folded/shaped for cavities

Polyester inner layer o� ers absorbency and fl exibility

Exsalt® dressings can absorb fi ve times their own weight and are compatible with other secondary dressings, such as KerraFoam™ and KerraMax Care™ dressings, if further absorption is required.

All layers are coated with Ag Oxysalts™ Technology

Exsalt® T7 dressing: Enhanced fl exibility

Exsalt® SD7 dressing: Enhanced absorption

EXSALT® DRESSINGS ARE TOUGH ON BACTERIA TO HELP WOUNDS PROGRESS TOWARDS HEALING.1,2

QUICKLY KILLS 99.999% OF A BROAD SPECTRUM OF BACTERIA1

DISRUPTS AND BREAKS DOWN in vitro BIOFILM TO EXPOSE BACTERIA2

Organisms tested to date:Gram-Negative• Acinetobacter baumannii• Escherichia coli• Pseudomonas aeruginosa• Klebsiella pneumoniae

Gram-Positive• Corynebacterium striatum• Enterococcus faecalis• Enterococcus faecalis VRE• Staphylococcus epidermidis• Staphylococcus aureus• Methicillin-resistant staphylococcus aureus (MRSA)

Fungus• Candida albicans• Aspergillus niger

1,000,000

100,000 1

2

3

4

5

10,000

1,000

100

10

1

Aquacel

Ag

Contro

l

Mepile

x Ag

Therab

ond 3D

Actico

at 7

Num

ber

of

Bac

tier

a/m

l

Log

Red

ucti

on

*4 hrs, 37°C, SWF, data on file

1

10

100

1,000

10,000

100,000

1,000,000

10,000,000

Ag3+

Ag Oxysalts™ Technology

Ag1+

Silver nitrate

Ag Ion Concentration [ppm]

0 17 34 50 67 100 135 150

P. a

erug

inos

a [

CF

U/m

L]

in vitro studies show Ag Oxysalts™ Technology disrupts and kills P. aeruginosa biofilm.

Molar concentrations of Ag Oxysalts™ Technology

were used to measure kill rates and to determine

e�cacy vs. biofilms after 24 hour exposure

using the Calgary biofilm device evaluating

MBEC and following the device manufacturer’s

protocol; biofilms were grown for 24 hours,

then confirmed and visualized using microscopy

and staining; e�cacy was demonstrated vs. P.

aeruginosa, S. aureus, and E. coli biofilms.

KILLS BACTERIA FOR UP TO 7 DAYS1

In a in vitro assay, exsalt ® dressings were shown

to maintain its antimicrobial activity against a

broad spectrum of bacteria for up to 7 days. This reduces the need for frequent dressing

changes and unnecessary disturbance to the

wound.

Exsalt®

dressing

Re-innoculation

4 log reduction

1 2 3 4 5 6 7

8.0

7.0

6.0

5.0

4.0

3.0

2.0

1.0

0.0

Log

Bac

teri

al C

oun

t (1

0%

)

Days

Antibacterial activity*

Anti-bacterial Activity of Ag Oxysalts™ Technology within Established in vitro Biofilm

EXSALT® DRESSINGS ARE GENTLE ON PATIENTSAND YOUR BUDGET

MINIMAL STINGING OR PAIN VS. ACTICOAT®7 DRESSING3

COST EFFECTIVE

pH

leve

l

Time (minutes)15 30 45 60 90 120

6

7

8

9

10

11

12

13

14Acticoat® 7 dressing

Exsalt®dressing

exsalt® dressings demonstrated only

a nominal shift in pH, at markedly

lower silver concentration compared

to most competitors. This means that

patients experience minimal pain, so

that comfort can be increased without

compromising on biocidal

e� ectiveness.

As Ag Oxysalts™ Technology is highly e� cacious, less silver is required in the dressing. This means the silver coatings

can be deposited more e� ciently on the dressing. This signifi cantly lowers production costs and results in a more

cost-e� cient solution. In fact, Exsalt® dressings o� er signifi cant cost savings in comparison to Acticoat® 7

dressings, over seven-day use.

can be deposited more e� ciently on the dressing. This signifi cantly lowers production costs and results in a more

cost-e� cient solution. In fact, Exsalt® dressings o� er signifi cant cost savings in comparison to Acticoat® 7

dressings, over seven-day use.

order information

to place an order please call 855-522-2211*All photos are property of their respective owners.

dressing size product code dressings per box hcpcs codeExsalt® T7 4” x 5” PN-09-0103 10

Exsalt® T7 4” x 8” PN-09-0104 10

Exsalt® T7 6” x 6” PN-09-0105 10

Exsalt® T7 6” x 9” PN-09-0106 10

Exsalt® T7 8” x 16” PN-09-0108 10

Exsalt® T7 16” x 16” PN-09-0116 5

Exsalt® T7 4” x 48” PN-09-0120 5

Exsalt® SD7 2” x 2” PN-09-0004 5 A6251

Exsalt® SD7 4” x 5” PN-09-0005 5 A6252

Exsalt® SD7 6” x 6” PN-09-0007 5 A6252

Crawford Healthcare Inc. | 2005 South Easton Rd. | Suite 203 | Doylestown, PA 18901Tel 855-522-2211 | Email us.info@crawfordhealthcare.comwww.crawfordhealthcare.com/us

Exsalt and Ag Oxysalts are registered trademarks of Exciton Technologies. All other trademarks are property of their respective owners. © Copyright Crawford Healthcare Ltd, 2014.

References: 1. Log reduction testing for Exsalt T7 Dressing.Data on fi le 2009, Crawford Healthcare Ltd. 2. Miller S. etal. Antimicrobial silver in medical devices: Composition and effi cacy. Poster presented at: Spring meeting of Symposia on Advanced Wound Care; May 2013; Denver, CO. 3. In vitro Cytotoxicity Evaluation: Mamalian Fibroblast Cells. Data on File. Crawford Healthcare Ltd. 4. Spina C. Silver I, II, III: Chemical Characteristics, Properties, and Anti-microbial Activity. Data on fi le. Crawford Healthcare Ltd.

CH14009-US

burn*

diabetic Foot ulcer* surgical wound*

leg ulcer* pressure ulcer*

usE Exsalt® drEssings on chronic and acutE wounds that arE inFEctEd or at risK oF inFEction